DR. PETER J GOLDBLATT, M.D.
Medical Practice at Arlington Ave, Toledo, OH
License number
Ohio 35023729
Category
Medical Practice
Type
Anatomic Pathology
Address
Address
3000 Arlington Ave, Toledo, OH 43614
Phone
(419) 383-3470
(419) 383-6130 (Fax)
(419) 383-7146
(419) 383-2050 (Fax)
(419) 383-6130 (Fax)
(419) 383-7146
(419) 383-2050 (Fax)
Personal information
See more information about PETER J GOLDBLATT at radaris.comName
Address
Phone
Toledo, OH
2303 Evergreen Rd, Ottawa Hills, OH 43606
Professional information
See more information about PETER J GOLDBLATT at trustoria.com
Peter J Goldblatt, Toledo OH
Peter J Goldblatt, Toledo OH
Specialties:
Pathologist
Address:
3355 Glendale Ave, Toledo, OH 43614
Education:
Case Western Reserve University, School of Medicine - Doctor of Medicine
University Hospitals - Case Medical Center - Residency - Pathology
University Hospitals - Case Medical Center - Residency - Pathology
Board certifications:
American Board of Pathology Certification in Anatomic Pathology (Pathology)
Dr. Peter J Goldblatt, Toledo OH - MD (Doctor of Medicine)
Dr. Peter J Goldblatt, Toledo OH - MD (Doctor of Medicine)
Specialties:
Anatomic Pathology
Address:
3000 Arlington Ave, Toledo 43614
(419) 383-3470 (Phone), (419) 383-6130 (Fax)
(419) 383-3470 (Phone), (419) 383-6130 (Fax)
Certifications:
Anatomic Pathology, 1965
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
3000 Arlington Ave, Toledo 43614
St. Luke's Hospital
5901 Monclova Rd, Maumee 43537
St. Luke's Hospital
5901 Monclova Rd, Maumee 43537
Education:
Medical School
Case Western Reserve University School of Medicine
Graduated: 1959
University Hospitals Of Cleveland
West Res
Case Western Reserve University School of Medicine
Graduated: 1959
University Hospitals Of Cleveland
West Res
Bioartificial Pancreas
Bioartificial Pancreas
US Patent:
5387237, Feb 7, 1995
Filed:
Jul 21, 1993
Appl. No.:
8/094946
Inventors:
Ronald L. Fournier - Sylvania OH
Peter J. Goldblatt - Toledo OH
James M. Horner - Sylvania OH
Jeffrey G. Sarver - Rossford OH
Peter J. Goldblatt - Toledo OH
James M. Horner - Sylvania OH
Jeffrey G. Sarver - Rossford OH
Assignee:
The University of Toledo - Toledo OH
International Classification:
A61F 202, A61F 200, A61M 3700, A61M 532
US Classification:
623 11
Abstract:
An implantable bioartificial pancreas device having an islet chamber containing glucose responsive and insulin-secreting islets of Langerhans or similar hormone secreting cells, the islet chamber having baffle means inside thereof to assist in even distribution of the islets in the chamber, one or more vascularizing chambers open to surrounding tissue, a semi-permeable membrane between the islet and vascularizing chambers that allows passage of small molecules including insulin, oxygen and glucose and does not allow passage of agents of the immune system such as white cells and antibodies, the vascularizing chambers containing a growth factor soaked fibrous or foam matrix having a porosity of about 40 to 95%, the matrix providing small capillary growth and preventing the blood from clotting in the lower chamber.
Bioartificial Pancreas
Bioartificial Pancreas
US Patent:
5855616, Jan 5, 1999
Filed:
Sep 3, 1996
Appl. No.:
8/711364
Inventors:
Ronald L. Fournier - Sylvania OH
Peter J. Goldblatt - Toledo OH
James M. Horner - Sylvania OH
Jeffrey G. Sarver - Rossford OH
Peter J. Goldblatt - Toledo OH
James M. Horner - Sylvania OH
Jeffrey G. Sarver - Rossford OH
Assignee:
The University of Toledo - Toledo OH
International Classification:
A61F 202, A61F 200
US Classification:
623 11
Abstract:
An implantable bioartificial pancreas device having an islet chamber containing glucose responsive and insulin-secreting islets of Langerhans or similar hormone secreting cells, one or more vascularizing chambers open to surrounding tissue, a semi-permeable membrane between the islet and vascularizing chambers that allows passage of small molecules including insulin, oxygen and glucose and does not allow passage of agents of the immune system such as white cells and antibodies, the vascularizing chambers containing a growth factor soaked fibrous or foam matrix having a porosity of about 40 to 95%, the matrix providing small capillary growth and preventing the blood from clotting in the lower chamber.
Bioartificial Pancreas
Bioartificial Pancreas
US Patent:
5674289, Oct 7, 1997
Filed:
Jan 6, 1995
Appl. No.:
8/369708
Inventors:
Ronald L. Fournier - Sylvania OH
Peter J. Goldblatt - Toledo OH
James M. Horner - Sylvania OH
Jeffrey G. Sarver - Rossford OH
Peter J. Goldblatt - Toledo OH
James M. Horner - Sylvania OH
Jeffrey G. Sarver - Rossford OH
Assignee:
The University of Toledo - Toledo OH
International Classification:
A61F 202, A61M 3700
US Classification:
623 11
Abstract:
An implantable bioartificial pancreas device having an islet chamber containing glucose responsive and insulin-secreting islets of Langerhans or similar hormone secreting cells, one or more vascularizing chambers open to surrounding tissue, a semi-permeable membrane between the islet and vascularizing chambers that allows passage of small molecules including insulin, oxygen and glucose and does not allow passage of agents of the immune system such as white cells and antibodies, the vascularizing chambers containing a growth factor soaked fibrous or foam matrix having a porosity of about 40 to 95%, the matrix providing small capillary growth and preventing the blood from clotting in the lower chamber.
Bioartificial Pancreas
Bioartificial Pancreas
US Patent:
5425764, Jun 20, 1995
Filed:
Dec 1, 1993
Appl. No.:
8/161172
Inventors:
Ronald L. Fournier - Sylvania OH
Peter J. Goldblatt - Toledo OH
James M. Horner - Sylvania OH
Jeffrey G. Sarver - Rossford OH
Peter J. Goldblatt - Toledo OH
James M. Horner - Sylvania OH
Jeffrey G. Sarver - Rossford OH
Assignee:
The University of Toledo - Toledo OH
International Classification:
A61F 202, A61M 3700
US Classification:
623 11
Abstract:
An implantable bioartificial pancreas device having an islet chamber containing glucose responsive and insulin-secreting islets of Langerhans or similar hormone secreting cells, one or more vascularizing chambers open to surrounding tissue, a semi-permeable membrane between the islet and vascularizing chambers that allows passage of small molecules including insulin, oxygen and glucose and does not allow passage of agents of the immune system such as white cells and antibodies, the vascularizing chambers containing a growth factor soaked fibrous or foam matrix having a porosity of about 40 to 95%, the matrix providing small capillary growth and preventing the blood from clotting in the lower chamber.